The pharma sector is expected to finish as the top performer in 2024, closely followed by realty while the third spot could be occupied by consumer durables. Eight other sectors posted double-digit returns, outperforming the BSE Sensex on a year-to-date basis, while energy, FMCG, banking and manufacturing lagged behind.
BSE Healthcare’s 2024 return on Monday, December 23 was 39% with 9 stocks giving multibagger returns between 207% and 100%. Wockhardt, Indraprastha Medical Corporation, Newland Laboratories, Vimata Labs, Shilpa Medicare, Orchid Pharma, Supriya Lifesciences, Windlass Biotech and Solara Active Pharma.
